USPTO serial 99087192
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Randolph E Digges, III
Randolph E Digges, III RANKIN, HILL & CLARK LLPP.O. Box 1150Bonita Springs, FL 34133-1150United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biotechnological diagnostic preparations used in science, non-medical reagents, enzymes and chemicals, namely buffer solutions, used in analytical chemistry, for scientific and/or medical research use for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and for the analysis of biopolymers, in particular nucleic acids, in particular reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning; chemical test kits for laboratory and research use for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and for the analysis of biopolymers, in particular nucleic acids, in particular comprising reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning | ACTIVE | Jun 12, 2024 |
| 005 | Diagnostic preparations for medical and veterinary purposes, namely diagnostics preparations for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and/or for the analysis of biopolymers, namely nucleic acids; diagnostic reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning for medical or veterinary purposes; chemical, biochemical and biotechnological diagnostic preparations for medical and veterinary purposes, namely reagents, enzymes and buffer solutions for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and for the analysis of biopolymers, namely nucleic acids; diagnostic kits containing preparations for medical and veterinary diagnostic purposes, namely for marking, separating, isolating, amplifying, reverse transcribing, cloning, sequencing and for the analysis of biopolymers, namely nucleic acids; diagnostic kits containing reagents, enzymes and buffer solutions for nucleic acid amplification, reverse transcription and cloning for medical or veterinary purposes | ACTIVE | Jun 12, 2024 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 11, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 11, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 23, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 23, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 17, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 26, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 26, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 26, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 26, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 26, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 25, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 25, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 25, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 15, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 17, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 17, 2025 | NWAP | NEW APPLICATION ENTERED | — |
| Mar 17, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |